J. D. Sar

Clinical evaluation of AZD1152, an i.v. inhibitor of Aurora B kinase, in patients with solid malignant tumors.

J. Schellens, David M. Wilson, E. Voest, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I evaluation of telatinib, a VEGF receptor tyrosine kinase inhibitor, in combination with irinotecan and capecitabine in patients with advanced solid tumors

J. Schellens, E. Voest, H. Verheul, 2008 .